>

>

Assess the biosimilars market and create a medical affairs strategy to prepare for biosimilar launches

Service Areas
Therapeutic Areas

Oncology

Client Type

Big Pharma

Client Problems

  • A large biopharmaceutical company wants to assess the regulatory and clinical biosimilars market to enable informed treatment decision making in the best interest of patients

What We Did

  • Developed a U.S. biosimilars landscape and identified the key events and policy changes
     

  • Created a comprehensive MCL and MSL training plan
     

  • Conduct an on-site workshop to identify the Key Medical Objectives gaps and develop new tactics

Our Results And Insight

  • Explore Biosimilars Landscape


     

  • MSL / MCL training support


     

  • Realign teams and stakeholders. Describe scope of action

case_study_image_placeholder.png
case_study_image_placeholder.png
case_study_image_placeholder.png

See other case studies

Operation Strategy case studies >

Oncology case studies >

Service Areas Details

Operation Strategy (medical affairs)

Therapeutic Areas Details

Oncology (immunoncology)

Featured Consultants
Diana Starr

Diana Starr